---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-002266"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2024-01-12T23:59:59+00:00"
generated_at: "2026-06-06T23:52:23.028677+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioSig raises $1.04M in equity offering; sells shares and warrants

## Summary
- Gross proceeds of $1,040,000.11 from sale of 2,607,170 shares at $0.3989 per share.
- Warrants to buy 1,303,585 shares at $0.3364; exercisable after 6 months, expire in 5.5 years.
- Offering exempt from registration under Section 4(a)(2) and Rule 506 of the Securities Act.
- Shares and warrants sold to accredited and institutional investors on January 12, 2024.

## SEC filing metadata
- accession: 0001493152-24-002266
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2024-01-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000149315224002266/0001493152-24-002266-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000149315224002266/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-002266
- JSON: https://secwatch.observer/filing/0001493152-24-002266.json
- Plain text: https://secwatch.observer/filing/0001493152-24-002266.txt

## Key facts
- Material Agreements
  Streamex Corp. entered into Securities Purchase Agreement with certain accredited and institutional investors valued at gross proceeds from this offering were $1,040,000.11 (effective 2024-01-12).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain accredited and institutional investors
  - Value: gross proceeds from this offering were $1,040,000.11
  - Effective: 2024-01-12
  source text: On January 12, 2024, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited and institutional investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 2,607,170 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and warrants (the “Warrants”) to purchase up to 1,303,585 shares of Common Stock (the “Warrant Shares” and together with the Shares and the Warrants, the “Securities”), at a purchase price of $0.3989 per Share and a Warrant to purchase one-half of a Share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000149315224002266/0001493152-24-002266-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.